APTSTAT3-9R

General Information


DRACP ID  DRACP00492

Peptide Name   APTSTAT3-9R

Sequence  HGFQWPGSWTWENGKWTWKGAYQFLKGGGGSRRRRRRRRR

Sequence Length  40

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=10-20 μmol/L MTT assay 12h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  STAT3

Affinity  Not available

Mechanism  With the addition of a cell-penetrating motif, the resulting APTSTAT3-9R aptide was able to suppress the viability and proliferation of cancer cells by blocking STAT3 phosphorylation, thereby inhibiting STAT3 downstream signaling.

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00492

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C223H330N80O51

Absent amino acids  CDIMV

Common amino acids  R

Mass  564335

Pl  12.81

Basic residues  13

Acidic residues  1

Hydrophobic residues  9

Net charge  12

Boman Index  -16034

Hydrophobicity  -179.5

Aliphatic Index  12.25

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  28990

Absorbance 280nm  743.33

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24576829

Title  A Specific STAT3-Binding Peptide Exerts Antiproliferative Effects and Antitumor Activity by Inhibiting STAT3 Phosphorylation and Signaling

Doi 10.1158/0008-5472.CAN-13-2187

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.